Novo Nordisk releases results from first phase IIIa study of semaglutide for type 2 diabetes July 13, 2015
Ultragenyx reports Fast Track designation and 40-week treatment data of KRN-23 in pedriatic XLH July 10, 2015
City of Hope launches clinical trial of immune suppression strategy in islet transplantation July 9, 2015
RSS